Incidence of Neoplasm in Patients Referred for Epistaxis
Ear, Nose & Throat Journal · 2024
DOI: 10.1177/01455613231223946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, 2024. Verfasst von Nicholas Toomey und 3 weiteren Autor:innen. Beteiligte Einrichtung: UC Davis Health Department of Otolaryngology, Sacramento, CA, USA. Hauptthemen laut MEDLINE: Epistaxis, Nasopharyngeal Neoplasms, Nose Neoplasms, Nasopharyngeal Carcinoma. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The primary objective was to identify the incidence of neoplastic disease in patients referred for epistaxis. Secondary objectives included identification of any mass lesion, and the need for further workup with imaging and/or biopsy as well as risk factors associated with identification of a mass lesion. Study Design: Retrospective cohort study.
Methods
Medical records of adult patients who presented to Tufts Medical Center over an 11 year period (2010-2021) with a chief complaint of epistaxis were reviewed. The primary outcome was identification of a nasal or nasopharyngeal mass. Patient characteristics including age, sex, race, smoking status, anticoagulation, comorbidities (hypertension, allergic rhinitis, vasculitis), and treatment of epistaxis (used as surrogate for severity of epistaxis) were also examined.
Results
A total of 1164 patients met inclusion and exclusion criteria. Thirty-six nasal masses were found among patients presenting with epistaxis (3.09%, P < .001), comprised primarily of benign etiology (2.66%) including nasal polyposis and thornwaldt cyst. Asian race correlated with finding of mass lesion (75%, P = .007). Five malignancies were found (0.43%) including nasopharyngeal carcinoma (2 patients), extranodal natural killer T-cell lymphoma (2 patients), and nasal adenocarcinoma (1 patient).
Conclusions
Epistaxis is a common cause for referral to otolaryngology. Although the incidence of neoplasm in our patient population was low, nasal mass lesions warranting further workup were identified in 36 patients. Findings of neoplasm were more common in patients of Asian ethnicity, which may reflect the increased prevalence of nasopharyngeal carcinoma in this population. Otolaryngologic evaluation and nasal endoscopy should be considered in all cases of epistaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UC Davis Health Department of Otolaryngology, Sacramento, CA, USA.
- Tufts Medical Center Department of Otolaryngology, Boston, MA, USA.
ORCID-Profile: Nicholas Toomey
Zitieren
APA
Toomey, N., Hassanzadeh, T., O'Neil Danis, D., & Tracy, J. (2024). Incidence of Neoplasm in Patients Referred for Epistaxis. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231223946
Vancouver
Toomey N, Hassanzadeh T, O'Neil Danis D, Tracy J. Incidence of Neoplasm in Patients Referred for Epistaxis. Ear, Nose & Throat Journal. 2024. doi:10.1177/01455613231223946
BibTeX
@article{Toomey2024,
author = {Toomey, Nicholas and Hassanzadeh, Tania and O'Neil Danis, David and Tracy, Jeremiah},
title = {Incidence of Neoplasm in Patients Referred for Epistaxis},
journal = {Ear, Nose & Throat Journal},
year = {2024},
doi = {10.1177/01455613231223946}
}
EUVIMED